Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

Vaccines made in South Africa to stay in Africa

Thu, 2021-09-02 10:57 — mike kraft

Vaccines made in South Africa to stay in Africa, says envoy KAMPALA, Uganda (AP) — Vaccine doses produced by a plant in South Africa will no longer be exported to Europe following the intervention of South Africa’s government, the African Union's COVID-19 vaccine envoy said Thursday. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Vaccines made in South Africa to stay in Africa
Log in or register to post comments

Breakthough Infections Are Less Likely to Lead to Long COVID-- British Study Suggests

Thu, 2021-09-02 10:08 — mike kraft

Study: Vaccination lowers long Covid risk, even when people are infected The research is among the earliest evidence that immunization reduces the risk of long Covid even when a breakthrough infection occurs. Andrew Joseph STAT

People who are fully vaccinated against Covid-19 appear to have a much lower likelihood of developing long Covid than unvaccinated people even when they contract the coronavirus, a study published Wednesday indicated.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Breakthough Infections Are Less Likely to Lead to Long COVID-- British Study Suggests
Log in or register to post comments

Vaccinations: U.S vaccination rate has risen by 17 % since FDA gave full approval to Phizer vaccine

Wed, 2021-09-01 13:08 — mike kraft

First vaccination doses up 17 percent since Pfizer approval: analysis The number of Americans who have received their first dose of a COVID-19 vaccine has risen by 17 percent since Pfizer's was granted full approval by the Food and Drug Administration (FDA) last week, Joseph Choi TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Vaccinations: U.S vaccination rate has risen by 17 % since FDA gave full approval to Phizer vaccine
Log in or register to post comments

VAccine Resistance Part II: Analysis of the organized anti-Vaccine momvement

Wed, 2021-09-01 12:53 — mike kraft

As the coronavirus began pushing the nation into lockdown in March 2020, Joshua Coleman, an anti-vaccine campaigner who organizes anti-vaccine rallies, went on Facebook Live to give his followers a rallying speech. He laid out what he thought the pandemic really was: an opportunity.

“This is the one time in human history where every single human being across this country, possibly across the planet, but especially in this country, are all going to have an interest in vaccination and vaccines,” he said. “So it’s time for us to educate.”

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about VAccine Resistance Part II: Analysis of the organized anti-Vaccine momvement
Log in or register to post comments

Vaccine resistance, Part I: Grocery workers were on the front lines of the pandemic — so why so many still unvaccinated?

Wed, 2021-09-01 12:46 — mike kraft

Grocery workers were on the front lines of the pandemic — so why do so many remain unvaccinated? “I could see us doing [a vaccine mandate] if people were dying like crazy,” said one worker who has resisted calls from his employer to get vaccinated. NBC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

new study finds Moderna creates more antibodies than Pfizer doses

Tue, 2021-08-31 10:44 — mike kraft

Surprising new study finds Moderna creates more antibodies than New research suggests Moderna’s vaccine elicits more immune cells. Alexandra Kelley TheHill

Individuals vaccinated against COVID-19 with the Moderna option showcased higher antibody levels than those vaccinated with the Pfizer-BioNTech jab, according to results from a new study.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about new study finds Moderna creates more antibodies than Pfizer doses
Log in or register to post comments

Overview: Possible new varient, Europe, Japan developments

Tue, 2021-08-31 10:19 — mike kraft

What you need to know about the coronavirus right now Here's what you need to know about the coronavirus right now: Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Overview: Possible new varient, Europe, Japan developments
Log in or register to post comments

Even with the Delta variant, the ability of COVID-19 vaccines to prevent hospitalization hasn't significantly dropped, CDC scientist says

Tue, 2021-08-31 10:01 — mike kraft

Even with the Delta variant, the ability of COVID-19 vaccines to prevent hospitalization hasn't significantly dropped, CDC scientist says Since the Delta variant appeared, vaccine effectiveness against hospitalization ranged from 75% to 95%, Dr. Sara Oliver said. Sarah Al-Arshani YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

CDC report details vaccination and illness rates among U.S. adolescents.

Mon, 2021-08-30 19:46 — mike kraft

COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021 | MMWR (cdc.gov)

As of July 31, 2021, coverage with ≥1 dose of COVID-19 vaccine among adolescents aged 12–17 years was 42%, and 32% had completed the series. Series completion rates varied widely by state, ranging from 11% to 60%, and was 25% for adolescents aged 12–13 years, 30% for those aged 14–15 years, and 40% for those aged 16–17 years.

Improving adolescent COVID-19 vaccination coverage is crucial to reduce COVID-19–associated morbidity and mortality among adolescents and can help facilitate safer reopening of schools for in-person learning.

Country / Region Tags:

General Topic Tags: